Aptose Biosciences buy melinda
Start price
24.03.21
/
50%
€5.50
Target price
24.03.22
€5.50
Performance (%)
-15.64%
End price
01.05.21
€4.64
Summary
This prediction ended on 01.05.21 with a price of €4.64. The prediction for Aptose Biosciences disappointed with a performance of -15.64%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Aptose Biosciences | - | - | - | - |
iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
According to melinda what are the pros and cons of Aptose Biosciences for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Aptose Biosciences diskutieren
Buy mit Kursziel 5,5
In the thread Trading Aptose Biosciences
Buy beendet
Stopped prediction by melinda for Aptose Biosciences
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
12.01.20
12.01.20
-
04.11.21
04.11.21
0.00%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.08
11.12.19
11.12.19
-
12.01.20
12.01.20
34.80%
12.01.20
12.01.20
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€1.81
26.05.19
26.05.19
€2.71
05.07.19
05.07.19
49.91%
05.07.19
05.07.19
Could be worthwhile Investment >10% per year